Journal Article

DKFZ-2019-03247

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Influence of family history on risk of second primary cancers and survival in squamous cell skin cancer patients.

Chattopadhyay, S. (First author)DKFZ* ; Zheng, G.DKFZ* ; Hemminki, A.DKFZ* ; Försti, A.DKFZ* ; Sundquist, K. ; Sundquist, J. ; Hemminki, K. (Last author)DKFZ*

2020
Wiley-Blackwell Oxford

This record in other databases:  

Please use a persistent id in citations: doi:10.1111/bjd.18809

Abstract: Squamous cell skin cancer (SCC) patients have excellent prognosis but second primary cancers (SPCs) weaken survival prospects. Family history is a known risk factor for cancer but whether it is a risk factor for SPC in SCC patients is not known.Quantify the risk of family history on SPCs in SCC patients and estimate survival probabilities of patients with SPCs depending on family history.With 13,945 histologically verified SCCs, relative risks (RRs) were estimated for family history using a generalized regression model. For survival analysis, hazard ratios were assessed using a multivariable Cox-proportional hazard model.Family history of invasive SCC increased risk of second invasive SCC, RR = 42.92 (confidence intervals 33.69-50.32) compared to risk without family history RR 19.12 (17.88-21.08). Family history of any non-skin cancer in invasive SCC increased risk of the same cancers to be diagnosed as SPC; RRFH = 1.48 (1.35-1.61) vs. RRno FH = 1.40 (1.32-1.48); significant increases were observed for seven different non-skin cancers. Most results were replicated in in situ SCC. SPC was deleterious for survival irrespective of family history; hazard ratio for patients with SPC was 4.28 (3.83-4.72) compared to those without SPC (1.00).Family history of non-skin cancer was associated with approximately a doubling of risk for SPCs in SCC patients. SPC increases the death rate in SCC patients 3 to 4 times, irrespective of family history. Taking family history into account at SCC diagnosis may help prevention or early detection of SPCs.

Note: 2020 Sep;183(3):488-494 / #EA:C050#EA:C020#LA:C050#LA:C020#

---

Contributing Institute(s):

1. Molekular-Genetische Epidemiologie (C050)
2. C020 Epidemiologie von Krebs (C020)
3. B062 Pädiatrische Neuroonkologie (B062)
4. DKTK HD zentral (HD01)

Research Program(s):

1. 313 - Cancer risk factors and prevention (POF3-313) (POF3-313)

Appears in the scientific report 2020

---

Database coverage:
; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF >= 5 ; JCR ; NCBI Molecular Biology Database ; Nationallizenz ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Web of Science Core Collection

---